Key result
Doxorubicin causes ~10-fold higher mortality in H6PD knockout mice, revealing the ER pentose phosphate pathway's necessity.
Why the study?
The role of the endoplasmic reticulum pentose phosphate pathway in cardiomyocyte defense mechanisms against anthracycline-induced oxidative stress was unclear.
The endoplasmic reticulum pentose phosphate pathway, driven by H6PD, is essential for cardiomyocyte defense against doxorubicin-induced oxidative stress and cardiotoxicity.
Answers are grounded in this paper and cite their sources.
H6PD pathway modulation warrants no clinical change yet; leaves open its relevance as a therapeutic target in human anthracycline cardiotoxicity.
Anthracyclines’ cardiotoxicity involves an accelerated generation of reactive oxygen species. This oxidative damage has been found to accelerate the expression of hexose-6P-dehydrogenase (H6PD), that channels glucose-6-phosphate (G6P) through the pentose phosphate pathway (PPP) confined within the endoplasmic/sarcoplasmic reticulum (SR). To verify the role of SR-PPP in the defense mechanisms activated by doxorubicin (DXR) in cardiomyocytes, we tested the effect of this drug in H6PD knockout mice (H6PD−/−). Twenty-eight wildtype (WT) and 32 H6PD−/− mice were divided into four groups to be treated with intraperitoneal administration of saline (untreated) or DXR (8 mg/Kg once a week for 3 weeks). One week thereafter, survivors underwent imaging of 18F-deoxyglucose (FDG) uptake and were sacrificed to evaluate the levels of H6PD, glucose-6P-dehydrogenase (G6PD), G6P transporter (G6PT), and malondialdehyde. The mRNA levels of SR Ca2+-ATPase 2 (Serca2) and ryanodine receptors 2 (RyR2) were evaluated and complemented with Hematoxylin/Eosin staining and transmission electron microscopy. During the treatment period, 1/14 DXR-WT and 12/18 DXR-H6PD−/− died. At microPET, DXR-H6PD−/− survivors displayed an increase in left ventricular size (p < 0.001) coupled with a decreased urinary output, suggesting a severe hemodynamic impairment. At ex vivo analysis, H6PD−/− condition was associated with an oxidative damage independent of treatment type. DXR increased H6PD expression only in WT mice, while G6PT abundance increased in both groups, mismatching a generalized decrease of G6PD levels. Switching-off SR-PPP impaired reticular accumulation of Ca2+ decelerating Serca2 expression and upregulating RyR2 mRNA level. It thus altered mitochondrial ultrastructure eventually resulting in a cardiomyocyte loss. The recognized vulnerability of SR to the anthracycline oxidative damage is counterbalanced by an acceleration of G6P flux through a PPP confined within the reticular lumen. The interplay of SR-PPP with the intracellular Ca2+ exchanges regulators in cardiomyocytes configure the reticular PPP as a potential new target for strategies aimed to decrease anthracycline toxicity.
No takes yet. Share an insight, caveat, or question.
Sambuceti et al. (2023) studied Anthracycline-induced cardiotoxicity (n=60). Doxorubicin vs. Saline was evaluated on Mortality during the treatment period (H6PD-/- vs WT) (p=<0.001). Doxorubicin treatment caused significantly higher mortality in H6PD knockout mice (67%) compared to wildtype mice (7%), demonstrating the mandatory role of the endoplasmic reticulum pentose phosphate pathway in defending against anthracycline-induced redox stress.
Synapse has enriched 10 related papers. Consider them for comparative context: